Cardinal Health (CAH) Expected to Release Earnings on Thursday

Key Points

• Cardinal Health is expected to report Q1 fiscal 2027 results before markets open Thursday, November 5. Analysts forecast earnings of $2.94 per share and revenue of $66.67 billion, while the company’s full-year EPS guidance is $12.40–$12.60.
• The company beat estimates in its prior quarter, posting $2.91 EPS versus the $2.42 consensus, with revenue up 5.8% year over year to $63.67 billion.
• Analyst sentiment remains positive, with 16 Buy ratings and three Holds and an average price target of $269.38. However, insiders sold more than 210,000 shares worth approximately $49.6 million over the past 90 days.

Cardinal Health (NYSE:CAH - Get Free Report) will likely be announcing its Q1 2027 results before the market opens on Thursday, November 5th. Analysts expect Cardinal Health to post earnings of $2.94 per share and revenue of $66.67 billion for the quarter. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Parties can find conference call details on the company's upcoming Q1 2027 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The business had revenue of $63.67 billion during the quarter, compared to analysts' expectations of $65.15 billion. During the same quarter in the previous year, the business earned $2.08 EPS. The company's revenue for the quarter was up 5.8% on a year-over-year basis. On average, analysts expect Cardinal Health to post $12.55 EPS for the current fiscal year and $13.91 EPS for the next fiscal year.

Cardinal Health Stock Performance

NYSE CAH opened at $244.47 on Thursday. Cardinal Health has a one year low of $161.64 and a one year high of $259.21. The company's 50 day moving average price is $236.98 and its 200 day moving average price is $221.80. The firm has a market capitalization of $56.61 billion, a price-to-earnings ratio of 33.81, a PEG ratio of 1.50 and a beta of 0.50.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st were paid a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.8%. The ex-dividend date was Thursday, October 1st. Cardinal Health's payout ratio is currently 28.49%.

Insider Buying and Selling at Cardinal Health

In related news, insider Jessica Mayer sold 29,436 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total transaction of $6,952,488.84. Following the sale, the insider owned 33,076 shares of the company's stock, valued at $7,812,220.44. The trade was a 47.09% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Deborah Weitzman sold 7,354 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the sale, the chief executive officer directly owned 77,901 shares in the company, valued at $18,341,790.45. This trade represents a 8.63% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 210,271 shares of company stock worth $49,626,657. 0.12% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Mizuho increased their price objective on shares of Cardinal Health from $250.00 to $280.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 20th. Weiss Ratings upgraded shares of Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a report on Thursday, October 8th. TD Cowen upped their price target on shares of Cardinal Health from $275.00 to $280.00 and gave the stock a "buy" rating in a research report on Thursday, August 13th. Wells Fargo & Company upped their price target on shares of Cardinal Health from $245.00 to $277.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 12th. Finally, Citigroup increased their price target on Cardinal Health from $265.00 to $280.00 and gave the company a "buy" rating in a report on Wednesday, August 12th. Sixteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $269.38.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.